Controlled drug release from dendrimers
US8703907B2 · kind B2 · utility
12Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 2011 |
| Grant date | Apr 22, 2014 |
| Priority date | — |
| Expiry date | May 5, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08G83/004
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compositions that comprise dendrimers useful in medical and veterinary applications that provide controlled release of drugs, such as peptides, nucleic acids and small molecules. The drugs are covalently coupled to the dendrimer through a linkage that releases the drug or a prodrug through controlled beta elimination.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.